The New Frontier: Omnichannel Strategies for Pharma

Articles

Organiser: NEXT Pharma

Multichannel: The Way It Was.

It was a model that had endured for decades, and its foundation was the sales force.

Pharmaceutical companies developed new and effective products; their representatives met with health care providers and supplied samples and information.

As the company’s repertoire of medications expanded, the size of its sales sector swelled in lockstep.

Each new product demanded more representatives to directly engage health care providers and educate them on the benefits of the medication. It was all one-on-one...

Articles

Impatient Health

The DOL House: Turning DOLs into KOLs – a new way to nurture influence in pharma

Influence in pharma is changing. No longer do we have to choose between...

Thursday, 20 Jul 2023

Articles

Medical Affairs Value

The Big Takeaway From MAPS 2023 Nashville: Build Trust to Elevate Medical Affairs

Wow, the MAPS 2023 Nashville conference was amazing. I left feeling great. The...

Wednesday, 5 Apr 2023

Articles

MyMA Morsels: Snackable content from Industry KOLs

An introduction to BioGPT: part two of The Life Sciences Industry’s Guide to Surviving The Rise of the Robots

Author: Arthur Alston MD MBA (Connect on LinkedIn) Recently I started an immersion...

Tuesday, 28 Feb 2023

Articles

My Medical Affairs is a
Swipe Health Platform

My Medical Affairs is a Swipe Health Platform

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

The New Frontier: Omnichannel Strategies for Pharma

Dates

Topics

Formats

Organiser

Articles

The DOL House: Turning DOLs into KOLs – a new way to nurture influence in pharma

The Big Takeaway From MAPS 2023 Nashville: Build Trust to Elevate Medical Affairs

An introduction to BioGPT: part two of The Life Sciences Industry’s Guide to Surviving The Rise of the Robots

You are attempting to log out of MyMA

The New Frontier: Omnichannel Strategies for Pharma

Dates

Topics

Formats

Organiser

Articles

Related

The DOL House: Turning DOLs into KOLs – a new way to nurture influence in pharma

The Big Takeaway From MAPS 2023 Nashville: Build Trust to Elevate Medical Affairs

An introduction to BioGPT: part two of The Life Sciences Industry’s Guide to Surviving The Rise of the Robots

Accept Cookies?

You are attempting to log out of MyMA